Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

After tumor removal, the woman regained normal hormone levels, menstruated, and had a healthy baby.

High DHEA-S levels may cause hair loss in young men.

Herbal remedies like Asparagus racemosus and Tinospora cordifolia may help manage PCOS symptoms.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Cats with adrenal tumors may have both hyperaldosteronism and hyperprogesteronism.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Ovarian vein sampling can effectively locate ovarian tumors when imaging is unclear.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

COCs can improve acne but may cause skin issues like cholasma; high estrogen is advised for hair loss concerns.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.